9.4 Volatile Anesthetic & Subambient Gas Therapy

9.4 Volatile Anesthetic & Subambient Gas Therapy

Volatile Anesthetic Delivery in Refractory Bronchospasm

Isoflurane or sevoflurane may be used by a specialist critical-care and anesthesia team for life-threatening refractory status asthmaticus when conventional bronchodilators and ventilatory strategies fail. These agents relax airway smooth muscle but can cause dose-related hypotension, myocardial depression, dysrhythmia, and altered anesthetic depth. This is rescue therapy, not routine aerosol treatment.

System requirements

• Use a ventilator or anesthesia workstation compatible with the selected agent and an agent-specific calibrated vaporizer.
• Continuously measure inspired and expired anesthetic concentration, oxygen, carbon dioxide, delivered volume and pressure, blood pressure, ECG, temperature, and gas exchange.
• Connect an effective waste-anesthetic-gas scavenging system. Check the room and circuit for leaks to protect staff.
• Account for added apparatus dead space, resistance, humidification changes, and absorption into circuit materials.
• Keep a difficult-airway plan, vasoactive support, and treatment for malignant hyperthermia immediately available under institutional policy.

The team should set a response endpoint and wean the agent once bronchospasm and ventilator mechanics improve. Abrupt changes can unmask bronchospasm or hemodynamic effects, so coordinate adjustments with anesthesia and pharmacy.

Subambient Oxygen Mixtures

Subambient therapy delivers an inspired oxygen concentration below room air by blending air with nitrogen. It is used only in specialized cardiac centers for selected infants with excessive pulmonary blood flow, such as some single-ventricle lesions, while awaiting definitive palliation. The purpose is to raise pulmonary vascular resistance enough to rebalance pulmonary and systemic flow—not to normalize saturation.

Use a precision blender and analyzer capable of measuring below 21%, a sealed delivery system, continuous preductal and postductal saturation when appropriate, blood gases, lactate, blood pressure, urine output, and preferably regional perfusion trends. Prescribe a narrow target and stop if systemic oxygen delivery or perfusion worsens. Hypoventilation or carbon-dioxide addition is not interchangeable with nitrogen blending and should never be improvised. Every adjustment requires congenital-cardiology and critical-care direction.

Safety Checklist

1. Confirm the indication, target, reassessment time, and escalation endpoint.
2. Trace the gas source through blender, analyzer, humidifier, circuit, and patient interface.
3. Verify that monitors and ventilator algorithms are valid for the gas mixture.
4. Calculate supply duration with a protocol-defined transport reserve.
5. Prepare definitive airway and hemodynamic rescue for any deteriorating child.

Environmental and Circuit Failure Modes

Volatile agents can escape at the endotracheal-tube cuff, around circuit connectors, through uncuffed tubes, or from an ineffective scavenging interface. A room odor is not a quantitative monitor. Verify scavenging flow and alarms, minimize circuit disconnections, and follow occupational-exposure policy. Agent absorption by plastic and changes in humidification can delay wash-in or wash-out. Record inspired and expired concentration with the clinical response.

Hypotension during volatile therapy may reflect vasodilation, myocardial depression, dynamic hyperinflation, or worsening shock. Check expiratory flow, intrinsic PEEP, perfusion, and dose before reflexively increasing ventilation. Hyperthermia, rigidity, rising carbon dioxide, acidosis, or hyperkalemia should activate the malignant-hyperthermia response pathway.

For subambient oxygen, two analyzers or a redundant verification process may be required by the center. A falling saturation is expected only within a prescribed range; rising lactate, weak pulses, oliguria, altered cerebral or somatic regional trends, or acidosis signals inadequate systemic oxygen delivery. The safest answer on an exam is coordinated titration with congenital-cardiology monitoring, never an improvised nitrogen connection.

Handoff Requirements

A specialty-gas handoff names the indication, mixture or agent, source, delivery device, current setting, measured concentration at the airway, patient target, recent response, adverse effects, supply remaining, and next reassessment. For volatile therapy, include vaporizer setting, inspired and expired concentrations, scavenging status, blood pressure support, and the weaning endpoint. For subambient oxygen, include the cardiology-prescribed saturation and perfusion goals, analyzer result, lactate and gas trend, and contingency for accidental exposure to room air or 100% oxygen.

Stop conditions

Stop and stabilize when the measured agent or oxygen concentration differs from the prescription, scavenging fails, blood pressure or rhythm deteriorates, carbon dioxide rises unexpectedly, or systemic perfusion worsens. Then trace gas source, vaporizer or blender, analyzer sampling, humidifier, valves, circuit, and interface in order. Specialty-gas therapy is safe only when the team can independently verify what reaches the airway and rapidly return to conventional oxygen and ventilation.

Always document verification.

Specialist Boundary

Neither volatile anesthetic delivery nor subambient oxygen is a routine bedside improvisation. If calibrated delivery, independent gas analysis, scavenging, trained staffing, or the written failure plan is unavailable, escalate to the specialty team and use supported alternatives.